Myasthenia gravis (MG) should be classified according to antibody status (acetylcholine, MuSK, LRP4, titin), thymus (hyperplasia, neoplasia, atrophy), age at debut (< or >50 years), symptom ...

Myasthenia gravis (MG) should be subgrouped into early-onset, late-onset, thymoma, ocular, anti-MuSK, anti-LRP4 and antibody-negative MG. MG has a prevalence of 140 per million, and an annual ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.

Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG), one of two drugs that the company hopes will shake up the ...

Thymoma is a rare tumour originating from the thymic epithelial cells. Here, we present a rare case of thymoma in a female patient in her early 60s, who presented for a clinical emergency. The tumour ...

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our ...

Company has reported net profit after tax of Rs 8.91 Crore in latest quarter.The company’s top management includes Mr.Ravi Ghai, Mr.Gaurav Ghai, Mr.Romil Ratra, Mr.Bhavnesh Sawhney, Mr.Krishnakant ...